NewLimit
Consumer
Company overview
NewLimit is a biotech company that develops medicines to extend human healthspan through epigenetic reprogramming, a method that activates genes to restore youthful function in aging cells. Its early programs target the liver, immune system and blood vessels. Researchers there have produced three prototype medicines that reprogram liver cells, restoring their ability to process fat and alcohol. The company is based in South San Francisco.
NewLimit was founded by Coinbase CEO Brian Armstrong, along with Blake Byers and stem-cell scientist Jacob Kimmel. Armstrong's involvement matters: it links the company's funding and public profile to a well-known tech founder rather than a traditional biotech investor. Historically, the median salary is ~$155,000.
- Industry
- Consumer
- Headquarters
- South San Francisco, United States